Chip Davis, president and CEO of the Generic Pharmaceutical Association (GPhA) offered praise of a study published on May 9, 2016 in the Journal of the American Medical Association ( JAMA ) Internal Medicine . The new study revealed that from 2010 2012, in the United States, moOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
